Endometrial Scratching After Failed IVF: Does It Help?

A clinician passes a thin instrument through the cervix and deliberately makes a small injury to the endometrium, generally in a cycle before transfer. It is not the same as a diagnostic hysteroscopy, which examines the cavity, or an endometrial biopsy ordered for a specific suspected disorder. Scratching can be uncomfortable and may cause spotting. Ask whether the proposed procedure is part of research, whether analgesia is offered, and what condition the doctor believes it would treat.

The UK fertility regulator HFEA rates endometrial scratching amber for most IVF patients, meaning the evidence is conflicting. For recurrent implantation failure it cannot determine effectiveness from adequate-quality studies. That is different from a firm finding that it works or never works. Look for the live-birth outcome rather than changes to laboratory markers, and ask whether the evidence applies to your age, embryos and treatment history.

A useful post-cycle review documents embryo stage and grading, whether an embryo was tested and what the test can or cannot predict, endometrial findings, progesterone timing, transfer difficulty and relevant medical history. Doctors should also examine whether a uterine cavity abnormality is suspected. Not every failed transfer indicates a hidden uterine disorder; embryo developmental factors and chance remain important.

Ask, “Which finding in my record makes scratching preferable to proceeding without it?” Request an estimate of total cost, side effects and opportunity cost, and a clear explanation of why a particular next step is being recommended. Be cautious when bundled add-ons are offered without a separate informed-consent discussion. If tests are suggested, ask how a positive or negative result would actually change management.

A second opinion is particularly reasonable when repeated transfers have failed, your records are incomplete, or you are being asked to pay for multiple procedures without an individual diagnosis. Share retrieval and embryology summaries rather than only a discharge sheet. A fresh specialist may confirm the original plan, advise a cavity assessment when indicated or explain why avoiding extra interventions is also an active, evidence-based decision.

A review may reveal no correctable issue, even after extensive investigation. That finding is emotionally difficult, yet clinically useful: it can support proceeding with a standard well-managed transfer, discussing embryo availability, or taking time to reconsider options. It is reasonable to ask whether a suggested test will alter medication, transfer timing or choice of procedure. A test that yields interesting data but changes no decision can add expense without adding clarity.

HomeIVF is a doctor-led fertility-care model intended to reduce unnecessary visits, not to relocate IVF procedures into a residence. Depending on the individual plan and the service confirmed at an address, care may include teleconsultation, selected home blood collection or appropriately supervised injection support. The prescribing doctor must review monitoring and medicines. Ultrasound scans when required, egg retrieval, sperm preparation, embryology and embryo transfer need appropriately equipped medical facilities. Ask the team to identify which stage they can actually support, who is responsible, and where every non-home procedure will occur.

Ask your team to issue a concise written pathway: what the diagnosis is, which tests are still needed, which appointment is time-sensitive, and who signs off treatment changes. If costs are relevant, separate required treatment from optional additions and future storage or transfer fees. When more than one provider participates, request a single point of medical accountability. An organised handover is especially valuable if travel or work prevents frequent unscheduled visits.

Online information can help prepare questions but cannot determine whether a symptom requires a scan, a changed prescription or urgent examination. If you develop sudden severe pain, faintness, significant bleeding, breathlessness or another alarming symptom, use emergency medical services and inform the fertility team. Keep the phone number of the actual treating facility. A home-support promise is not a substitute for an emergency referral arrangement.

The useful next step is an individual discussion grounded in your reports, a documented treatment plan and clear consent. Home-supported care can be valuable when it is available and medically suitable, but it never replaces essential laboratory and clinical procedures. Ask the specialist to explain what is known, what remains uncertain and which decision actually needs to be made next.